Table 3. Correlations between patient serum TIMP-2 levels and clinical characteristics.
| Characteristics | Total | serum TIMP-2 levels | OR | 95% CI | p-value | |
| <36.6 ng/ml | ≥36.6 ng/ml | |||||
| All Cases | 84 | 42 (39.0%) | 42 (61.0%) | |||
| Age (years) | ||||||
| ≥65 | 45 | 19 (42.2%) | 26 (57.8%) | |||
| <65 | 39 | 23 (59.0%) | 16 (41.0%) | 0.508 | 0.213–1.214 | 0.189 |
| Gender | ||||||
| Male | 48 | 19 (39.6%) | 29 (60.4%) | |||
| Female | 36 | 23 (63.9%) | 13 (36.1%) | 0.37 | 0.151–1.043 | 0.179 |
| Stage | ||||||
| IIIA | 7 | 3 (42.9%) | 4 (57.1%) | |||
| IIIB | 62 | 33 (53.2%) | 29 (46.8%) | |||
| IIIC | 10 | 6 (60.0%) | 4 (40.4%) | |||
| IVA | 3 | 0 | 3 (100%) | |||
| IVB | 2 | 0 | 2 (100%) | 0.215 | ||
| Histological type | ||||||
| Adenocarcinoma | 67 | 33 (49.3%) | 34 (50.7%) | |||
| Mucus adenocarcinoma | 14 | 8 (57.1%) | 6 (42.9%) | |||
| Others | 3 | 1 (33.3%) | 2 (66.7%) | 0.728 | ||
p-value calculated by the Chi-square test.